Cargando…
IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic of severe coronavirus disease 2019 (COVID-19). Staphylococcus aureus is one of the most common pathogenic bacteria in humans, rheumatoid arthritis (RA) is among the most prevalent autoimmune conditions....
Autores principales: | Zheng, Qingcong, Wang, Du, Lin, Rongjie, Lv, Qi, Wang, Wanming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520788/ https://www.ncbi.nlm.nih.gov/pubmed/36189314 http://dx.doi.org/10.3389/fimmu.2022.1013322 |
Ejemplares similares
-
SARS-CoV-2 induces “cytokine storm” hyperinflammatory responses in RA patients through pyroptosis
por: Zheng, Qingcong, et al.
Publicado: (2022) -
DNA Sensor IFI204 Contributes to Host Defense Against Staphylococcus aureus Infection in Mice
por: Chen, Wei, et al.
Publicado: (2019) -
Identification and Validation of IFI44 as Key Biomarker in Lupus Nephritis
por: Shen, Lingling, et al.
Publicado: (2021) -
Molecular Prerequisites for Neutrophil Extracellular Trap Formation and Evasion Mechanisms of Staphylococcus aureus
por: von Köckritz-Blickwede, Maren, et al.
Publicado: (2022) -
Ets1 and IL17RA cooperate to regulate autoimmune responses and skin immunity to Staphylococcus aureus
por: Battaglia, Michael, et al.
Publicado: (2023)